Award
Delivery Order #SPE2DR26F6Z5G
Delivery Order for Novolog Insulin Vials from AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$879.00
Ceiling
$879.00
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26F6Z5G
NAICS
424210
This award is a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, under an existing indefinite delivery vehicle focused on pharmaceutical products. The contract procures Novolog insulin, specifically 100 unit/ml 10ml vials, intended for medical use. This delivery order supports critical healthcare supply chains by ensuring availability of essential insulin products, vital for diabetes care. The scope includes timely delivery of specified pharmaceutical products to the designated location in Conshohocken, Pennsylvania during a short-term, multi-day period in early 2026. The order follows a competitive vehicle acquisition framework established by the parent indefinite delivery contract, highlighting continuity in procurement strategy and supply reliability. This contract reinforces the agency's commitment to maintaining steady access to life-sustaining medications benefiting patients and healthcare providers.
Description
4570837828!NOVOLOG 100 UNIT/ML VIAL 10ML